Brittany Taylor1, Adnan Cheema1, Louis Soslowsky2. 1. McKay Orthopaedic Laboratory, University of Pennsylvania, Stemmler Hall 36th Street and Hamilton Walk, Philadelphia, PA, 19104, USA. 2. McKay Orthopaedic Laboratory, University of Pennsylvania, Stemmler Hall 36th Street and Hamilton Walk, Philadelphia, PA, 19104, USA. soslowsk@upenn.edu.
Abstract
PURPOSE OF REVIEW: Hypercholesterolemia (HC), or high cholesterol, is usually caused by diet, other health conditions, or inherited diseases, such as familial hypercholesterolemia (FHC). Studies have shown patients with hypercholesterolemia are more prone to tendon injury and impaired healing. Nonetheless, the mechanism by which high cholesterol alters the biochemical and biomechanical properties of tendon and the healing environment is not well defined. This review highlights scientific findings on the relationship between hypercholesterolemia and treatments and tendon pathology at the cellular and tissue level. RECENT FINDINGS: The release of pro-inflammatory cytokines and upregulation of matrix-degrading proteins in hypercholesterolemic conditions leads to an increase in tendon stiffness and elastic modulus. The effect of hypercholesterolemia drugs, such as statins, on tendon pathology remains unclear. More insight into the relationship between HC and tendon pathology can lead to improved imaging modalities and therapeutics for tendinopathy in hypercholesterolemic patients.
PURPOSE OF REVIEW: Hypercholesterolemia (HC), or high cholesterol, is usually caused by diet, other health conditions, or inherited diseases, such as familial hypercholesterolemia (FHC). Studies have shown patients with hypercholesterolemia are more prone to tendon injury and impaired healing. Nonetheless, the mechanism by which high cholesterol alters the biochemical and biomechanical properties of tendon and the healing environment is not well defined. This review highlights scientific findings on the relationship between hypercholesterolemia and treatments and tendon pathology at the cellular and tissue level. RECENT FINDINGS: The release of pro-inflammatory cytokines and upregulation of matrix-degrading proteins in hypercholesterolemic conditions leads to an increase in tendon stiffness and elastic modulus. The effect of hypercholesterolemia drugs, such as statins, on tendon pathology remains unclear. More insight into the relationship between HC and tendon pathology can lead to improved imaging modalities and therapeutics for tendinopathy in hypercholesterolemicpatients.
Authors: Ana M Bea; Sofia Perez-Calahorra; Victoria Marco-Benedi; Itziar Lamiquiz-Moneo; Estibaliz Jarauta; Rocio Mateo-Gallego; Fernando Civeira Journal: Atherosclerosis Date: 2017-06-08 Impact factor: 5.162
Authors: Graham P Riley; Valerie Curry; Jeroen DeGroot; Benno van El; Nicole Verzijl; Brian L Hazleman; Ruud A Bank Journal: Matrix Biol Date: 2002-03 Impact factor: 11.583
Authors: Thomas Kirchgesner; Ahmed Larbi; Patrick Omoumi; Jacques Malghem; Nadia Zamali; Julien Manelfe; Frédéric Lecouvet; Bruno Vande Berg; Sahlya Djebbar; Benjamin Dallaudière Journal: Joint Bone Spine Date: 2014-06-21 Impact factor: 4.929
Authors: Neal L Millar; Karin G Silbernagel; Kristian Thorborg; Paul D Kirwan; Leesa M Galatz; Geoffrey D Abrams; George A C Murrell; Iain B McInnes; Scott A Rodeo Journal: Nat Rev Dis Primers Date: 2021-01-07 Impact factor: 52.329
Authors: Tomas Fernandez-Jaén; Fernando Sanz-Zapata; Jesus Manuel Cortés; Ramon Balius-Mata; Guillermo Alvarez-Rey; Jose Ignacio Garrido-Gonzalez; Carlos Colmenero-Rolon; Isabel Recio-Alvarez; Pedro Guillen-Garcia Journal: Orthop J Sports Med Date: 2020-08-31
Authors: Maria Pia Adorni; Marta Biolo; Francesca Zimetti; Marcella Palumbo; Nicoletta Ronda; Paolo Scarinzi; Paolo Simioni; Maria Giovanna Lupo; Nicola Ferri; Lorenzo Previato; Franco Bernini; Alberto Zambon Journal: Int J Mol Sci Date: 2022-07-26 Impact factor: 6.208
Authors: Zuhier Ahmed Awan; Omran M Rashidi; Bandar Ali Al-Shehri; Kaiser Jamil; Ramu Elango; Jumana Y Al-Aama; Robert A Hegele; Babajan Banaganapalli; Noor A Shaik Journal: Front Med (Lausanne) Date: 2021-06-25